Late last month, the Association of Corporate Counsel (ACC) hosted a panel on artificial intelligence and how it is rapidly transforming the life sciences sector, allowing companies to leverage large datasets to accelerate...more
5/2/2024
/ Artificial Intelligence ,
Clinical Trials ,
Consent ,
EU ,
General Data Protection Regulation (GDPR) ,
Life Sciences ,
Personal Data ,
Pharmaceutical Industry ,
Privacy Notice Rule ,
Public Interest ,
Research and Development ,
Transparency
Late last month, the Association of Corporate Counsel (ACC) hosted a panel on Trade Secret Protection in Life Sciences: Strategies for Success. In today's rapidly evolving business environment, trade secrets are becoming...more
4/26/2024
/ Confidentiality Agreements ,
Corporate Counsel ,
Cybersecurity ,
Employees ,
Intellectual Property Protection ,
Life Sciences ,
Misappropriation ,
Policies and Procedures ,
Remote Working ,
Trade Secrets ,
Training
On May 10, 2023, I attended the Association for Corporate Counsel (ACC) live CLE event "2023 Life Sciences Conference: Future-Ready Resilience: Preparing to Face Challenges in the Uncertain Future." Eric Long, executive vice...more
In the last ten years, more data and greater computing power have led to a boom in AI-related patent applications, with life and medical sciences emerging as a top application field. In 2021, more than 100 applications...more
6/1/2023
/ Artificial Intelligence ,
Biotechnology ,
Center for Drug Evaluation and Research (CDER) ,
Corporate Counsel ,
Emerging Technologies ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Machine Learning ,
PHI ,
Regulatory Agenda ,
Research and Development ,
State Privacy Laws ,
USDA
Investigatory review requires substantially more aggressive tactics than most other litigation review matters. Not all data has the same evidentiary significance. In fact, most data is noise that impedes case story building....more
The ACC last month hosted the San Francisco Bay Area Life Sciences CLE Conference, giving TransPerfect Legal Solutions (TLS) team members the opportunity to learn and connect with colleagues. One of the panels, moderated by...more
Earlier this month, the ACC hosted an illuminating panel presentation on Life Sciences Litigation: A Look at Milestone Disputes & Recent Trends. Panelists included Lauri Mims and Jennifer Huber, both Partners at Keker Van...more
5/20/2022
/ Acquisitions ,
Biotechnology ,
Business Valuations ,
Buyers ,
Contract Drafting ,
Contract Negotiations ,
Contract Terms ,
Earn-Outs ,
Life Sciences ,
Mergers ,
Milestone Payments ,
Pharmaceutical Industry ,
Research and Development ,
Sellers